Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00900419 · ClinicalTrials.gov registry record

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

A clinical trial of Lung Cancer and Head and Neck Cancer, sponsored by University of Colorado, Denver.

Recruiting
Registry status
700
Enrollment target
1
Study location

NCT00900419 is a study of Lung Cancer and Head and Neck Cancer that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 700 participants, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00900419, a study of Lung Cancer and Head and Neck Cancer, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
700 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Studying samples of sputum and tissue in the laboratory from patients with dysplasia or cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This laboratory study is looking at biomarkers in patients with respiratory tract dysplasia or lung cancer, head and neck cancer, or aerodigestive tract cancer.

Conditions Studied

Lung Cancer Head and Neck Cancer Esophageal Cancer Precancerous Condition

Interventions

  • OTHER laboratory biomarker analysis
  • PROCEDURE biopsy
  • OTHER immunohistochemistry staining method
  • OTHER sputum cytology

Study Locations (1)

Colorado

  • University of Colorado Cancer Center at UC Health Sciences Center - Aurora

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2001-05-03
Est. Completion 2027-09-30

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00900419

The ClinicalTrials.gov registry entry for NCT00900419 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target (25% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which laboratory biomarker analysis is the first listed.

NCT00900419 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT00900419 about?

NCT00900419 is a clinical study titled "Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers". RATIONALE: Studying samples of sputum and tissue in the laboratory from patients with dysplasia or cancer may help doctors identify and learn more about biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This laboratory study is looking at biomarkers in patie...

What is the current status of trial NCT00900419?

This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2001-05-03. Estimated completion is 2027-09-30.

What conditions does trial NCT00900419 study?

This clinical trial studies the following conditions: Lung Cancer, Head and Neck Cancer, Esophageal Cancer, Precancerous Condition.

What interventions are being tested in trial NCT00900419?

The interventions under investigation include: laboratory biomarker analysis (OTHER), biopsy (PROCEDURE), immunohistochemistry staining method (OTHER), sputum cytology (OTHER).

Who is sponsoring clinical trial NCT00900419?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00900419 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Head and Neck Cancer

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.